Is Fate Therapeutics Inc (NASDAQ:FATE), -70.46% Below Its High, Poised For A Strong Recovery?
In last trading session, Fate Therapeutics Inc (NASDAQ:FATE) saw 2.9 million shares changing hands with its beta currently measuring 1.93. Company’s recent per share price